Company / EPS (Diluted)
Adaptive Biotechnologies Corp EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.56
FY2025
5-year range
-$1.56 / -$1.01
FY2021-FY2025
Trend
-11.4%
vs FY2024
Sector context
#105 of 204
Health Care
What the data says
At $-1.56, Adaptive Biotechnologies Corp's eps (diluted) ranks #105 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 7 years, ranging from $-3.67 in FY2020 to $-1.01 in FY2021.
Based on SEC 10-K filings.
-1.56 in FY2025.
Declined from $-1.48 to $-1.56 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 204 in Health CareTop 51% of 204This company -$1.56 Sector average -$0.98
▼
-59.2% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 11.4% year-over-year.
- Ranks #105 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.56 | -11.4% |
| FY2024 | -$1.40 | +5.4% |
| FY2023 | -$1.48 | -33.3% |
| FY2022 | -$1.11 | -9.9% |
| FY2021 | -$1.01 | +72.5% |
| FY2020 | -$3.67 | -4.9% |
| FY2019 | -$3.50 | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026